Female reproductive system neoplasm
MONDO:0021148A benign, precancerous, or malignant neoplasm that affects the female reproductive system. Representative examples include uterine corpus leiomyoma, endocervical polyp, ovarian carcinoma, cervical carcinoma, and endometrial carcinoma.
Also known as: female reproductive organ neoplasm (disease), female reproductive organ tumor, female reproductive organ tumour, female reproductive system neoplasm, female reproductive system neoplasm (disease), female reproductive system tumor, female reproductive system tumour, gynecologic neoplasm
3680 clinical trials for this condition and its sub-types, 27 tagged with Female reproductive system neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Female reproductive system neoplasm
-
Female reproductive organ cancer 245 trials · 2,252 incl. sub-types
9 sub-types
- Uterine cancer 95 trials · 1,261 incl. sub-types Sub-types →
- Ovarian cancer 1,002 trials · 1,198 incl. sub-types Sub-types →
- Fallopian tube cancer 298 trials · 408 incl. sub-types Sub-types →
- Endometrioid adenocarcinoma 12 trials · 144 incl. sub-types Sub-types →
- Vulva cancer 88 trials · 102 incl. sub-types Sub-types →
- Vaginal cancer 53 trials · 60 incl. sub-types Sub-types →
- Adenosarcoma 0 trials · 2 incl. sub-types Sub-types →
- Gestational choriocarcinoma 0 trials · 1 incl. sub-types Sub-types →
- Adenocarcinofibroma 0 trials Sub-types →
-
Tumor of uterus 10 trials · 1,432 incl. sub-types
6 sub-types
- Uterine cancer 95 trials · 1,261 incl. sub-types Sub-types →
- Uterine cervix neoplasm 39 trials · 731 incl. sub-types Sub-types →
- Endometrium neoplasm 478 trials · 687 incl. sub-types Sub-types →
- Corpus uteri neoplasm 1 trial · 191 incl. sub-types Sub-types →
- Uterine benign neoplasm 3 trials · 112 incl. sub-types Sub-types →
- Placenta neoplasm 0 trials · 6 incl. sub-types Sub-types →
-
Ovarian neoplasm 78 trials · 1,213 incl. sub-types
8 sub-types
- Ovarian cancer 1,002 trials · 1,198 incl. sub-types Sub-types →
- Ovarian epithelial tumor 14 trials · 664 incl. sub-types Sub-types →
- Ovarian germ cell tumor 9 trials · 13 incl. sub-types Sub-types →
- Ovarian sex cord-stromal tumor 1 trial · 7 incl. sub-types Sub-types →
- Ovarian benign neoplasm 1 trial Sub-types →
- Ovarian endometrioid stromal and related neoplasms 0 trials
- Ovarian melanoma 0 trials
- Rete ovarii neoplasm 0 trials Sub-types →
-
Fallopian tube neoplasm 199 trials · 417 incl. sub-types
5 sub-types
- Fallopian tube cancer 298 trials · 408 incl. sub-types Sub-types →
- Fallopian tube mucinous tumor 1 trial · 10 incl. sub-types Sub-types →
- Fallopian tube endometrioid tumor 3 trials
- Fallopian tube benign neoplasm 0 trials Sub-types →
- Fallopian tube germ cell tumor 0 trials Sub-types →
-
Benign female reproductive system neoplasm 5 trials · 117 incl. sub-types
7 sub-types
- Uterine benign neoplasm 3 trials · 112 incl. sub-types Sub-types →
- Adenomyoma 1 trial · 3 incl. sub-types Sub-types →
- Ovarian benign neoplasm 1 trial Sub-types →
- Adenofibroma 0 trials Sub-types →
- Benign vaginal neoplasm 0 trials Sub-types →
- Fallopian tube benign neoplasm 0 trials Sub-types →
- Vulvar benign neoplasm 0 trials Sub-types →
-
Vulvar neoplasm 6 trials · 107 incl. sub-types
9 sub-types
- Vulva cancer 88 trials · 102 incl. sub-types Sub-types →
- Vulvar squamous neoplasm 0 trials · 28 incl. sub-types Sub-types →
- Vulvar glandular neoplasm 0 trials · 5 incl. sub-types Sub-types →
- Bartholin gland neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Clitoris neoplasm 0 trials Sub-types →
- Germ cell tumor of the vulva 0 trials Sub-types →
- Paraurethral gland neoplasm 0 trials Sub-types →
- Vulvar benign neoplasm 0 trials Sub-types →
- Vulvar granular cell tumor 0 trials
-
Endometrioid tumor 1 trial · 89 incl. sub-types
1 sub-type
- Ovarian endometrial cancer 4 trials · 88 incl. sub-types Sub-types →
-
Vaginal neoplasm 2 trials · 61 incl. sub-types
7 sub-types
- Vaginal cancer 53 trials · 60 incl. sub-types Sub-types →
- Vaginal squamous tumor 0 trials · 8 incl. sub-types Sub-types →
- Vaginal glandular neoplasm 0 trials · 7 incl. sub-types Sub-types →
- Vaginal melanoma 1 trial
- Benign vaginal neoplasm 0 trials Sub-types →
- Endometrioid stromal and related neoplasms of the vagina 0 trials Sub-types →
- Extraovarian Brenner tumor of the vagina 0 trials
-
Gestational trophoblastic neoplasm 7 trials · 8 incl. sub-types
6 sub-types
- Gestational choriocarcinoma 0 trials · 1 incl. sub-types Sub-types →
- Hydatidiform mole, recurrent, 1 1 trial
- Epithelioid trophoblastic tumor 0 trials
- Hydatidiform mole, recurrent, 2 0 trials
- Invasive hydatidiform mole 0 trials
- Placental site trophoblastic tumor 0 trials
-
2 sub-types
-
1 sub-type
Most studied deeper sub-types
-
Can a new immune drug outsmart Hard-to-Treat tumors?
Disease control Recruiting nowThis trial tests an experimental drug called STAR0602, which is designed to help the immune system attack cancer cells. It is being studied in people with advanced solid tumors that have not responded to standard treatments. The drug is given alone or combined with chemotherapy, …
Phase 1/2 • Sponsor: Marengo Therapeutics, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug cocktail aims to fight tough gynecological cancers
Disease control Recruiting nowThis study tests a drug called relacorilant, taken as a pill, combined with two standard chemotherapy drugs (nab-paclitaxel and bevacizumab) in people with ovarian, fallopian tube, peritoneal, or endometrial cancers. The goal is to see if the combination can slow cancer growth or…
Phase 2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for hard-to-treat cancers: combo drug trial launches
Disease control Recruiting nowThis study tests a new drug called mocertatug rezetecan (Mo-Rez) combined with other cancer medicines for people with advanced solid tumors that have stopped responding to standard treatments. About 305 adults will join to see if the combination is safe, tolerable, and effective.…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New ultrasound technique could sharpen ovarian cancer detection
Diagnosis Recruiting nowThis study tests a new ultrasound technique called microvessel imaging (UMI) to see if it can better detect small blood vessels in ovarian lesions, which may indicate cancer. Forty women scheduled for ovarian surgery will receive both standard and UMI ultrasounds. Doctors will co…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
AI-Powered camera could spot cervical cancer without a lab
Diagnosis Recruiting nowThis study is testing a new, low-cost screening tool for cervical cancer that uses artificial intelligence to analyze digital images of the cervix. It does not require a lab and can be used at the point of care. The goal is to see if this AI tool can accurately detect precancerou…
Sponsor: DL Analytics • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Reiki during cancer treatment: a new way to ease anxiety?
Symptom relief Recruiting nowThis study tests whether Reiki therapy can reduce anxiety and pain in people receiving brachytherapy for gynecologic cancers. 70 participants will either receive Reiki or standard care during their treatment. Researchers will measure changes in anxiety, pain, and mood using quest…
Phase 2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
8,000-Patient study aims to sharpen cancer radiation with Real-Time MRI
Knowledge-focused Recruiting nowThis study is a large registry that will follow about 8,000 cancer patients who receive radiation therapy using a special machine called an MR-Linac, which combines an MRI scanner with a radiation beam. The goal is to learn how well this technology works for different cancers, in…
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Can frailty predict cancer recovery? new study aims to find out
Knowledge-focused Recruiting nowThis study follows 500 adults with newly diagnosed gynecologic cancer to understand how frailty—a state of increased vulnerability—impacts their recovery and quality of life. Researchers will assess physical function, collect questionnaires, and review surgical outcomes. The goal…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC